Aurobindo Pharma acquires 7 oncology products from US-based firm

The acquisition was for an upfront purchase price of $160mn in cash plus up to $140mn (aggregating ~Rs2,125cr) on achieving regulatory and sales-based milestones.

from India Infoline News Service https://ift.tt/2ISGuFv